Infectolocus

La Medicina es el Arte de lo posible.

[Rheuma Doc @LastManStand85]

bDMARDs & their impact on the immune system and their vaccination strategies.. 💉 #Rheumatology #MedTwitter

[Dr. Sezen Arslan @sezenalsra]

Yüksek lisans/doktora tezi yazanlar ve her disiplinden akademisyenler için, bugün literatür taramasını kolaylaştıracak ve zevkli hale getirecek bir uygulamadan bahsetmek istiyorum. Eğer Google Akademik’de alt alta makale listesi incelemekten sıkıldıysanız, gelin bakalım 😊

Bu araç, https://t.co/qXNeKCAuCj Üyelik vs. istemiyor. Açık erişimli bir araç. Türkçe arama da yapabiliyorsunuz.

>>>Anahtar kelime yazıp aratıyorsunuz, size en alakalı 100 makaleyi güncel olarak görsel bir harita şeklinde sunuyor.

>>>Benzer konulara sahip makaleleri, küme içinde topluyor. Böylece, çalışma alanınızda öne çıkan alt başlıkları saniyeler içerisinde görebiliyorsunuz.

>>>Harita üzerinde makalelerden hangisinin açık erişimli olduğunu açıkça belirtiyor.

>>>BASE ve PubMeb gibi iki büyük veri tabanı kullanması da güzel bir özelliği.

Sizler için hazırladığım kısa tanıtım videosunu aşağıda bulabilirsiniz.

📍Bu paylaşımım hesabımdaki diğer yapay zekâ araçları tanıtımında olduğu gibi, herhangi bir sponsorluk ya da ticari bir işbirliği değildir. Sadece bizzat deneyimlediğim akademik verimliliği artırdığına inandığım araçları araştırmacılara yol gösterme niyetiyle paylaşmaktayım.

[Alí Sebastian Meza @AliSMV7]

Reframing sepsis through resistance, disease tolerance and damage: a clinically meaningful conceptual shift?

https://t.co/JBWAQltnds

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

For years, the need for longer durations in immunocompromised patients was treated as the exception to every shorter-duration bacteremia discussion.
BALANCE may have finally put that belief to rest.
Dogma continues to lose ground.
@BradSpellberg

[Alí Sebastian Meza @AliSMV7]

Overview of novel cefepime-based β-lactam/β-lactamase inhibitor combinations

https://t.co/QlJyOdY4W9

[Paola Miglio @paolamiglio]

Centro Histórico de Lima. Comer y Beber. En @ElTrinchecom hicimos la guía completa en PDF para que se la descarguen en su celular o cumpu. No pesa. Está en inglés y español y se la pueden bajar de este link https://t.co/JyiIZnjRcw

[S.Enf.Infecciosas HRUM @infeccHRUmalaga]

Que #antiséptico usarías para insertar un #catéter?
a) Povidona Iodada(Betadine)🌕
b) Clorhexidina alcohólica🍸
c) Clorhex acuosa💦
@JAMA #Metanalisis💻16 ens. clín👉🏻#ClorhexidinaAlcoholica menor infeccion relacionadas catéter y menor colonización📉🧫
🆓🔗https://t.co/HXk6MGO1o3

[MICROBIOLOGÍA - Hospital Clínico de Valencia @MicroClinicoVLC]

ANTIBIOGRAMA:
🌍EUCAST actualiza el documento de correlación entre el halo de inhibición (mm)🧫📏 y la CMI (mg/L)💊📊, para las principales bacterias y antibióticos más utilizados.
🔄Se actualizará con nuevos antibióticos, especies y datos de validación.
🔗https://t.co/s5HVAIYCcR

[Alí Sebastian Meza @AliSMV7]

Invasive candidiasis in critically ill patients fundamental concepts and future directions

https://t.co/9f3FYovBMd

[Alí Sebastian Meza @AliSMV7]

Pulmonary fungal infections in the immunocompetent host

https://t.co/Yk3BAU24Zm

[SEIMC @SEIMC_]

📢 #DivulgaciónSEIMC | El siguiente análisis retrospectivo de @JGLOBHEALTH analiza más de 3.000 brotes de #enfermedades infecciosas en cerca de 100 países a nivel global entre 1996 y 2023, basándose en informes de #emergencias de @WHO

Este tipo de estudios es de gran utilidad para una #vigilancia dirigida y estrategias proactivas que permita priorizar regiones vulnerables y #patógenos de alto riesgo en políticas de #salud pública

➡️ Artículo facilitado por @micromunidad

Léelo aquí 👇
https://t.co/Rag5i812Xi

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕⚡Evaluating hypoalbuminaemia thresholds associated with delayed blood sterilization among patients receiving cefazolin or antistaphylococcal penicillins for MSSA bacteraemia
After propensity score weighting, patients with an albumin level of ≤3.0 g/dL had a significantly slower time to blood culture sterilization compared with patients with albumin levels >3 g/dL (HR = 0.6; 95% CI: 0.44–0.81; P < 0.01) @DrToddLee #IDXposts
Among the 461 patients screened, 285 patients met the inclusion criteria; 34% (97/285) were people who inject drugs and 45% (130/285) had definite endocarditis . #IEWiki https://t.co/YKbBHAIt6k

[S.Enf.Infecciosas HRUM @infeccHRUmalaga]

En @CIDJournal si una #neumonía🫁 tiene determinación➕a virus NO necesariamente precisa asociar antibiótico❌💊.Trabajo con 6799 pacientes👉🏻 0-2 días antibiótico🟰5-7 días en mortalidad⚰️ e ingreso UCI🛌💨
Importante OPORTUNIDAD #Stewardship/PROA🩻🧐
🔗🆓https://t.co/qSKFFCtn3m

[Alí Sebastian Meza @AliSMV7]

Treatment of pulmonary mucormycosis: current concepts

https://t.co/Lr6TDPjMpH

[Mauricio Ambriz @AmbrizMau]

Representación esquemática del espectro de la tuberculosis (TB), que abarca desde la eliminación espontánea, la infección latente por Mycobacterium tuberculosis, la TB incipiente, la TB subclínica y la enfermedad activa:

Clin Microbiol Rev 2026:e0019425.

[Juan E Losa. Infectólogo. HUFA. URJC. Sandoval Sur @juanelosag]

Los resultados de este estudio sugieren que “el desescalado precoz de la antibioterapia empírica de amplio espectro en los pacientes con sepsis y sin aislamiento de microorganismos multirresistentes es eficiente y segura” https://t.co/9ZKTdKEfXz

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕⚡🌟Narrative Review @CMIJournal
Mechanisms of resistance to newer drugs against Gram negative bacteria in Enterobacterales #IDXposts
https://t.co/EthDAXZWA5

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Imipenem/relebactam Resistance
The relebactam inhibitor differs from other DBOs in that it contains a piperidine ring in the position 2. This prevents binding to OXA-48 and GES-5 . Relebactam is a potent KPC inhibitor that is active against certain KPC-3 variants (KPC-80 and KPC-81) and KPC-2 (KPC-28 and KPC-57) variants, which are resistant to avibactam. Generally, resistance to the imipenem/relebactam combination is primarily caused by changes in porins. Furthermore, most resistant isolates have also been found to possess KPC variants (e.g. V239G, D179N/Y, S106L, N132S, L167R) or to exhibit increased KPC production. However, these factors alone rarely confer high-level resistance to this combination unless accompanied by porin mutations

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕⚡Risk factors for progression from Clostridioides difficile colonization (NAAT+/toxin–) to infection (toxin+) following symptomatic retesting #IDXposts
https://t.co/vA6kW4KHAr

[Alí Sebastian Meza @AliSMV7]

Current Management Strategies for Hypervirulent Klebsiella

https://t.co/moVpGFGzKE